Innovus Pharmaceuticals to Release Third Quarter 2
Post# of 405
Posted On: 11/07/2016 1:25:30 PM
Innovus Pharmaceuticals to Release Third Quarter 2016 Financial Results and Provide Corporate Update on Thursday, November 10, 2016
SAN DIEGO--(November 07, 2016)--Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (OTCQB: INNV), today announced that the Company will release its third quarter 2016 financial results and provide a corporate update on Thursday, November 10, 2016, after the close of the U.S. financial markets. The Company will host a conference call at 4:30 p.m. ET/1:30 p.m. PT on the same day to discuss the financial results and recent business developments. To participate in the call, please dial 1-877-883-0383 for domestic callers or 1-412-902-6506 for international callers. Participant Elite Entry Number: 3007123. A replay of the call will be available for 30 days. To access the replay, dial 1-877-344-7529 domestically or 1-412-317-0088 internationally and reference Conference ID: 10096488. The replay will be available shortly after the end of the conference call.
*** Get your questions/comments ready. Love this Mgt team - love the conf call approach, per usual ! Now Go BUY some products
Number to beat IMO is $1.72M for Q3 in terms of Revenue. Would also like to see margins at 67% or higher.
SAN DIEGO--(November 07, 2016)--Innovus Pharmaceuticals, Inc., (“Innovus Pharma”) (OTCQB: INNV), today announced that the Company will release its third quarter 2016 financial results and provide a corporate update on Thursday, November 10, 2016, after the close of the U.S. financial markets. The Company will host a conference call at 4:30 p.m. ET/1:30 p.m. PT on the same day to discuss the financial results and recent business developments. To participate in the call, please dial 1-877-883-0383 for domestic callers or 1-412-902-6506 for international callers. Participant Elite Entry Number: 3007123. A replay of the call will be available for 30 days. To access the replay, dial 1-877-344-7529 domestically or 1-412-317-0088 internationally and reference Conference ID: 10096488. The replay will be available shortly after the end of the conference call.
*** Get your questions/comments ready. Love this Mgt team - love the conf call approach, per usual ! Now Go BUY some products
Number to beat IMO is $1.72M for Q3 in terms of Revenue. Would also like to see margins at 67% or higher.
(1)
(0)Innovus Pharmaceuticals Inc. (INNV) Stock Research Links
Scroll down for more posts ▼